(Q69253630)

English

The advantages of a gonadotropin releasing hormone agonist (leuprolide acetate) in conjunction with gonadotropins for controlled ovarian hyperstimulation in IVF and GIFT cycles

scientific article published on 01 January 1989

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2511810%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

The advantages of a gonadotropin releasing hormone agonist (leuprolide acetate) in conjunction with gonadotropins for controlled ovarian hyperstimulation in IVF and GIFT cycles (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2511810%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

1 reference

based on heuristic

inferred from title

author name string

J F Kerin

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2511810%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

publication date

1 January 1989

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2511810%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

Archives of Gynecology and Obstetrics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2511810%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

246 Suppl

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2511810%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

S45-52

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2511810%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

https://scigraph.springernature.com/pub.10.1007/bf00935852

0 references

An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2511810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The neuroendocrine control of the menstrual cycle.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2511810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short-term use of gonadotropin-releasing hormone agonist (leuprolide) for in vitro fertilization

1 reference

https://pubmed.ncbi.nlm.nih.gov/2511810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pregnancy: a risk to initiation of leuprolide acetate during the luteal phase before controlled ovarian hyperstimulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/2511810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment

1 reference

https://pubmed.ncbi.nlm.nih.gov/2511810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women

1 reference

https://pubmed.ncbi.nlm.nih.gov/2511810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q69253630&oldid=2132335626"